Corline Biomedical: Regulatory approval in Canada - Redeye
Bildkälla: Stockfoto

Corline Biomedical: Regulatory approval in Canada - Redeye

Redeye is positive about Kardium’s regulatory approval in Canada for the Globe system. While the approval was expected, it marks further progress in Kardium’s market expansion, with Europe next in line. We continue to view the US as the primary market opportunity, but believe the company’s continued expansion into new geographies supports the long-term commercial potential of the Globe system.

Redeye is positive about Kardium’s regulatory approval in Canada for the Globe system. While the approval was expected, it marks further progress in Kardium’s market expansion, with Europe next in line. We continue to view the US as the primary market opportunity, but believe the company’s continued expansion into new geographies supports the long-term commercial potential of the Globe system.
Börsvärldens nyhetsbrev